L-dopachrome tautomerase (197-205)

L-dopachrome tautomerase (197-205) is a synthetic peptide fragment derived from the active region of L-dopachrome tautomerase, an enzyme integral to melanin biosynthesis and pigment cell biology. This peptide encompasses residues 197 to 205 of the parent protein, a region implicated in modulating enzymatic activity and protein-protein interactions within melanogenic pathways. As a well-defined sequence, it serves as a valuable molecular tool for dissecting the structure-function relationships of melanogenic enzymes, enabling researchers to probe the biochemical mechanisms underpinning pigment formation and cellular signaling processes.

Enzymatic mechanism studies: The 197-205 peptide fragment is frequently employed in research focused on elucidating the catalytic mechanism of L-dopachrome tautomerase. By isolating this specific domain, investigators can examine its contribution to substrate recognition and catalysis, providing insight into the molecular determinants that govern enzyme specificity and efficiency. Such studies are critical for understanding how subtle sequence variations influence the conversion of L-dopachrome to 5,6-dihydroxyindole, a key step in melanin synthesis.

Protein interaction analysis: Researchers utilize the 197-205 region to investigate interactions between L-dopachrome tautomerase and its binding partners. Synthetic peptides corresponding to this sequence can serve as molecular probes in binding assays, pull-down experiments, or surface plasmon resonance studies to map interaction sites and characterize affinity. This approach facilitates the identification of regulatory proteins or cofactors that modulate enzyme function within the pigmentary system.

Epitope mapping and antibody development: The defined sequence of the 197-205 peptide makes it an ideal candidate for use in epitope mapping and the generation of sequence-specific antibodies. By employing this fragment as an immunogen or as a target in antibody screening assays, researchers can develop reagents that selectively recognize the active or regulatory domains of L-dopachrome tautomerase. These antibodies are instrumental in immunodetection protocols, including Western blotting, immunoprecipitation, and immunohistochemistry, advancing studies of protein localization and expression.

Peptide-based inhibitor screening: The 197-205 sequence can be incorporated into assays designed to screen for small molecules or peptides that disrupt critical functional regions of L-dopachrome tautomerase. By targeting this segment, researchers can identify compounds that modulate enzyme activity, offering a pathway to dissect regulatory mechanisms or develop new research tools for pigment cell biology. Such screening assays are essential for expanding the repertoire of molecular probes available for functional studies.

Structural biology applications: As a representative fragment of the enzyme's active region, the 197-205 peptide is valuable in structural studies employing techniques such as X-ray crystallography or nuclear magnetic resonance spectroscopy. By analyzing the conformation and dynamics of this peptide in isolation or in complex with ligands, scientists can gain detailed insights into the structural motifs responsible for enzymatic function and protein stability. These investigations contribute to a deeper understanding of the molecular architecture underlying melanogenic enzymes and their regulation.

1. Therapeutic potential of an intestinotrophic hormone, glucagon-like peptide 2, for treatment of type 2 short bowel syndrome rats with intestinal bacterial and fungal dysbiosis

2. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review

3. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry

4. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment

5. Tachykinin-related peptides modulate immune-gene expression in the mealworm beetle Tenebrio molitor L